Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction
NCT03658031
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
576
Enrollment
INDUSTRY
Sponsor class
Conditions
PreDiabetes
Myocardial Infarction
T2DM (Type 2 Diabetes Mellitus)
CVD
Interventions
DRUG:
Dapagliflozin 10mg
Sponsor
Hamad Medical Corporation